Study title:
Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4)Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood - a pilot project - Magdorf K, Arizzi-Rusche AF, Geiter LJ, O'Brien RJ et al - 1994 (Pneumologie, 48(10): 761 - 4)
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Bacterial Infections and Mycoses
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: RIFAMYCIN |
ATC code: J04AB03
|
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
-
|